Roth MKM analyst Matt Koranda keeps a Buy rating and $37 price target on Lovesac after the company’s better than expected Q2 revenue pre-announcement along with the announced delay in its Q2 report so as to refile past financial statements. The pre-announcement shows a stabilizing business that is inflecting on gross margins, and while the delay may disappoint some investors, the healthy underlying fundamentals in the business should still carry more weight, the analyst tells investors in a research note.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on LOVE:
- The Lovesac Company Reports Preliminary Second Quarter Fiscal Year 2024 Results
- Lovesac reports preliminary Q2 revenue $154M, consensus $149.66M
- Lovesac (NASDAQ:LOVE) Shares Fell Amid Overstated Income Disclosures
- Lovesac down 7% at $22.00 afterhours following restatement of financials
- Lovesac says FY23 net income overstated by $1M-$2M